Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy".
作者信息
Naganuma Makoto
机构信息
Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka, 573-1010, Japan.
出版信息
J Gastroenterol. 2024 Jul;59(7):643. doi: 10.1007/s00535-024-02113-y. Epub 2024 May 13.
PMID:38739201
Abstract
摘要
Zotero 插件